NuVasive (NUVA) Misses Q1 EPS by 6c; Reiterates Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as higher oil prices temper risk appetite after S&P record close
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Reddit to join S&P 500 index on Aug. 18, shares leap
- Should you chase this mini rally in gold? Citi weighs in
NuVasive (NUVA) PT Lowered to $65 at RBC Capital; 'Profitability Below Expectations'
May 2, 2018 8:37 AM EDTRBC Capital lowered its price target on NuVasive (NASDAQ: NUVA) to $65.00 (from $70.00) while maintaining a Sector Perform rating.
Analyst Glenn Novarro commented, "NUVA's revenue growth should re-accelerate throughout 2018 as new product launches gain traction. Additionally, NUVA will debut its surgical intelligence... More
BMO Capital Downgrades NuVasive (NUVA) to Market Perform
May 2, 2018 1:47 AM EDTBMO Capital downgraded NuVasive (NASDAQ: NUVA) from Outperform to Market Perform with a price target of $56.00 (from $70.00).
For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.
Shares of NuVasive closed at $53.14 yesterday.
... More